Drug Type AAV based gene therapy |
Synonyms adeno-associated viral vector serotype 2 containing the human SLC6A3 gene, BGT DTDS, BGTDTDS |
Target |
Action modulators |
Mechanism DAT modulators(Dopamine transporter modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States), Orphan Drug (European Union) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinsonism-Dystonia, Infantile | Preclinical | United States | - | |
Parkinsonism-Dystonia, Infantile | Preclinical | United Kingdom | - |